Previous evaluations of anti-measles and anti-rubella virus IgM detection methods resulted in the broad adoption of Enzygnost (most recently manufactured by Siemens) ELISA kits within WHO’s global measles and rubella laboratory network (8, 9). This evidence concerns the gene CD40LG and rubella.